Search
    
    
                
                
                
              
              
              Iguratimod is an anti-rheumatic agent.
The main mechanism of action of iguratimod is: by selectively inhibiting cyclooxygenase-2, thereby reducing the production of prostaglandins in inflammatory tissues, inhibiting the release of bradykinins in inflammatory tissues, inhibiting antigen-specific T cell proliferation, reducing the level of pro-inflammatory factors produced by B cells in patients with rheumatoid arthritis, stimulating osteoblast differentiation and bone construction, inhibiting synovial cell co-stimulating factor expression and cytokine production. It can inhibit the production of immunoglobulins, inhibit cytokine production, inhibit bone resorption and promote bone formation.
| Items | Specifications | Results | 
| Appearance | White crystalline powder | Complies | 
| Loss on Drying | ≤0.5% | 0.21% | 
| Related substance | ≤1.0% | 015% | 
| Assay | ≥99.0% | 99.85% | 
| Product parameters | |
| Cas number: | 123663-49-0 | 
| Appearance: | White crystalline powder | 
| Purity: | 99%min | 
| Package details: | 100g/bottle; 1kg/foil bag | 
| Brand: | Fortunachem | 

Iguratimod acts as an anti-inflammatory agent, used primarily in the treatment of rheumatoid arthritis.

      Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
        
      Quick Links
Add:
E-mail:
English                  
Español                  
français                  
العربية